Introduction
============

Beverages containing alcohol are commonly consumed in today's societies and often abused. The brain is one of the main targets of alcohol. Long-term excessive consumption of alcohol can change the brain and lead to a variety of behavioral changes such as addiction and cognitive dysfunction (Harper, [@B21]). Magnetic resonance imaging studies have showed reduced hippocampal and prefrontal cortex volume of individuals suffering from alcohol dependence that may contribute to the cognitive deficit associated with chronic alcohol exposure (Jernigan et al., [@B25]; Sullivan et al., [@B56]). These aversive effects may be associated with direct and indirect actions of alcohol on various neurotransmitter and neuropeptide systems within the central nervous system (CNS; Harris et al., [@B22]; Vengeliene et al., [@B61]; Spanagel, [@B53]). Among those neurotransmitter receptors, a special focus has been on the association of alcohol action and alcoholism with γ-aminobutyric acid type A (GABA~A~) ion channels during the last 30 years. Many GABA~A~ channel subunit genes have been suggested to be associated with human alcoholism (Korpi and Sinkkonen, [@B30]), but detailed mechanisms remain poorly known and are inconsistent between studies.

The GABA~A~ channels are GABA-gated anion channels that predominantly mediate inhibitory neurotransmission within CNS. Each GABA~A~ channel complex is formed by five homologous protein subunits and to date 19 GABA~A~ channel subunits (α1--6, β1--3, γ1--3, δ, ε, θ, π, and ρ1--3) have been identified in mammals (Olsen and Sieghart, [@B44]). The various combinations of different subunits and associated proteins account for the diverse pharmacological and biophysical properties of the GABA~A~ channel complex in the plasma membrane (Birnir and Korpi, [@B4]; Uusi-Oukari and Korpi, [@B60]). GABA~A~ channels in neurons are present at synapses and extrasynaptic sites and mediate fast phasic inhibition and persistent tonic inhibition, respectively (Mody and Pearce, [@B42]; Semyanov et al., [@B52]; Lindquist and Birnir, [@B36]; Jin et al., [@B26]). Although many previous studies have shown that alcohol potentiates GABA~A~ channels, how alcohol directly acts on GABA~A~ channels remains unclear (Korpi et al., [@B29]). Alcohol action on GABA~A~ channels depends on the concentration of alcohol and the channel subunits composition (Olsen et al., [@B43]). Some reports have demonstrated that low concentrations of alcohol (3--30 mM) can enhance the tonic inhibition mediated by extrasynaptic α4/6βδ GABA~A~ channels but not the phasic inhibition mediated by γ2-containing synaptic GABA~A~ channels (Sundstrom-Poromaa et al., [@B57]; Wallner et al., [@B65]; Wei et al., [@B66]; Borghese et al., [@B5]; Korpi et al., [@B29]; Baur et al., [@B1]). In contrast, high concentration of alcohol (\>60 mM) directly modulates GABA~A~ channels associated with phasic inhibition and the putative alcohol-binding site was identified in-between transmembrane domains 2 and 3 (Mihic et al., [@B40]). In addition to the acute alcohol effects on GABA~A~ channels, chronic exposure to alcohol can affect GABA~A~ channel functions via alterations in subunit expression, post-translational modification, localization, intracellular signaling, and neurosteroid response (Kumar et al., [@B31]). In rodent models, chronic alcohol administration differentially changes the expression levels of GABA~A~ channel subunit mRNAs and proteins across various brain regions (Grobin et al., [@B20]; Liang et al., [@B35]; Sarviharju et al., [@B50]). However, alcohol-dependent disorders in humans are not fully mimicked by rodent models. Therefore, studies conducted on samples from post-mortem brains of individuals suffering from alcohol dependence may add important information and aid in understanding the mechanisms underlying human alcohol-dependent disorders.

In the present study, we performed quantitative real-time PCR (RT-qPCR) to investigate the expression of GABA~A~ channel subunit mRNAs in the post-mortem hippocampal dentate gyrus, orbitofrontal, and dorsolateral prefrontal cortex (DL-PFC) of individuals suffering from alcohol dependence and have compared the results to brain samples from individuals without alcohol dependence.

Materials and Methods
=====================

Human samples
-------------

Twenty-one human controls and 19 individuals suffering from chronic alcohol dependence were included in the study. All individuals were Caucasian males. The individuals suffering from alcoholism consumed ≥80 g alcohol per day during the majority of their adult lives, met the criteria for Diagnostic and Statistical Manual for Mental Disorders, fourth edition and National Health and Medical Research Council/World Health Organization and did not have liver cirrhosis, Wernicke--Korsakoff's syndrome, or multi-drug abuse history. Individuals in the control group had either abstained from alcohol completely or were social drinkers who consumed ≤20 g of alcohol per day on average. Individuals in the control group were matched to individuals suffering from alcoholism by age and post-mortem interval (PMI). Post-mortem brain samples from hippocampal dentate gyrus (including both granule and molecular layer), orbitofrontal cortex (OFC; Brodmann's area 47), and DL-PFC (Brodmann's area 9) were collected at the New South Wales Tissue Resource Center (TRC), University of Sydney, Australia (<http://sydney.edu.au/medicine/pathology/trc/index.php>). The samples from all three brain regions were collected from the same donor in seven controls and ten individuals suffering from alcoholism. All samples were collected by qualified pathologists under full ethical clearance and with informed, written consent from the next of kin. The detailed demographic data for all subjects are given in Table [A1](#TA1){ref-type="table"} in Appendix.

Total RNA isolation
-------------------

Total RNA was isolated by using RNeasy Lipid Tissue Mini Kit (QIAGEN, MD, USA) or GenElute total RNA Miniprep (Sigma) and quantified with Nanodrop (Nanodrop Technologies, Inc.). The quality of RNA was evaluated by measuring RNA Quality Indicator (RQI) using Bio-Rad Experion (Bio-Rad Laboratories, Hercules, CA, USA) with Eukaryote Total RNA StdSens assay following the manufacturer's manual. RQI is equivalent to RNA integrity number (RIN) from Agilent (Denisov et al., [@B13]). RNA samples with RQI values greater than 5 are generally considered as suitable for RT-qPCR (Fleige and Pfaffl, [@B17]; Fleige et al., [@B18]). In this study, samples with RQI less than 5 were not used for experiments. Average RQI of the samples was 7.29 ± 0.12 (mean ± SEM; 83% samples have RQI greater than 6) indicating high quality of isolated total RNA.

Quantitative real-time RT-PCR
-----------------------------

Total RNA (250 ng) was reverse transcribed into cDNA in a 20 μl reaction mixture using Superscript III reverse transcriptase (Invitrogen). RT negative control was performed by omitting reverse transcriptase in the reaction in order to confirm no genomic DNA contamination in the isolated RNA. Real-time PCRs were performed in a 10 μl reaction mixture containing 4 μl cDNA (1 ng), 1 × PCR reaction buffer, 3 mM MgCl~2~, 0.3 mM dNTP, 1 × ROX reference dye, 0.8 U JumpStart *Taq* DNA polymerase (Sigma-Aldrich), 5 × SYBR Green I (Invitrogen), and 0.4 μM each of forward and reverse primers. The gene-specific primer pairs (primer sequences shown in Table [A2](#TA2){ref-type="table"} in Appendix) were designed using Primer Express Software version 3.0 (Applied Biosystems), synthesized by Invitrogen and further validated using BioBank cDNA from human brain (PrimerDesign). Amplification was performed in 384-well optical plates using the ABI PRISM 7900HT Sequence Detection System (Applied Biosystems) with an initial denaturation of 5 min at 95°C, followed by 45 cycles of 95°C for 15 s, 60°C for 30 s, and 72°C for 30 s. A melting curve was determined at the end of cycling to ensure the amplification of a single PCR product. Cycle threshold values (Ct) were determined with the SDS 2.3 and RQ Manager 1.2 softwares supplied with the instrument. The expression of each target gene relative to a normalization factor (geometric mean of two reference genes) was calculated with DataAssist v2.0 using the 2^−ΔCt^ method as previously described (Schmittgen and Livak, [@B51]). Reference genes beta actin (*ACTB*) and ubiquitin C (*UBC*) for hippocampal dentate gyrus (average expression stability value *M* = 0.25), ribosomal large P0 (*RPLP0*) and *ACTB* for prefrontal cortex (average expression stability value *M* = 0.22), and phosphoglycerate kinase 1 (*PGK1*) and peptidylprolyl isomerase A (*PPIA*) for OFC (average expression stability value *M* = 0.125) were selected for normalization according to previously developed approach for analysis of reference genes (Johansson et al., [@B27]; Kuzmin et al., [@B32]; Bazov et al., [@B2]). As the expression of reference genes may vary between different brain regions of human alcoholics, it is of great importance to use validated stable reference genes for normalization.

Statistical analysis
--------------------

Statistical analysis was carried out using SigmaPlot and SigmaStat (Systat Software Inc., USA). Normality of data distribution was analyzed using Shapiro--Wilk normality test (see Table [A3](#TA3){ref-type="table"} in Appendix). The differences between groups were assessed by one-way ANOVA with Bonferroni *post hoc* test (normally distributed data) or non-parametric Kruskal--Wallis ANOVA on ranks with Dunn's *post hoc* test (not normally distributed data). A general stepwise linear regression model was used to identify covariates (e.g., age and PMI). Variables with a significant association with group (controls and alcoholics) were included in the final statistical model as covariates. A significant level was set to *p* \< 0.05.

Results
=======

The demographic characteristics of individuals in this study are shown in Table [1](#T1){ref-type="table"} and Table [A1](#TA1){ref-type="table"} in Appendix. There was no significant difference in age, PMI, brain pH, RNA quality indicator, and proportions of smokers and non-smokers between individuals with or without alcohol dependence (Table [1](#T1){ref-type="table"}).

###### 

**Sample demographic information**.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Characteristics         Hippocampal dentate gyrus   Dorsolateral prefrontal cortex   Orbitofrontral cortex                                                                  
  ----------------------- --------------------------- -------------------------------- ----------------------- -------------- ------------ ------- ------------- ------------ -------
  Number                  15                          13                                                       15             14                   14            11           

  Age (years)             57 ± 3                      56 ± 4                           0.909                   59 ± 4         59 ± 4       0.981   59 ± 4        58 ± 5       0.774

  PMI (h)                 30 ± 4.8                    30 ± 4.9                         0.908                   27 ± 4.2       29 ± 4.2     0.777   27 ± 4.6      29 ± 4.7     0.763

  Brain pH                6.5 ± 0.05                  6.5 ± 0.05                       0.599                   6.5 ± 0.06     6.5 ± 0.07   0.458   6.6 ± 0.06    6.5 ± 0.13   0.714

  RNA quality indicator   6.9 ± 0.23                  6.6 ± 0.14                       0.23                    7.3 ± 0.31     7.8 ± 0.31   0.206   7.7 ± 0.99    7.6 ± 0.96   0.936

  Smoking history\*       8(67%) S,\                  9(82%) S,\                       0.64                    10 (77%) S,\   9(82%) S,\   1.0     10(77%) S,\   7(78%) S,\   1.0
                          4(33%) NS                   2(12%) NS                                                3 (23%) NS     2(18%) NS            3(23%) NS     2(22%) NS    
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*PMI, post-mortem interval; S, smoker; NS, non-smoker*.

*Age, PMI, brain pH, and RNA quality indicator are shown as mean ± SE, and the difference between controls and alcoholics was tested with Student's *t*-test or Mann--Whitney *U*-test*.

*\*Smoking histories are not available for all subjects. The proportion of smokers and non-smokers between controls and alcoholics was tested with Fisher's exact test*.

Expression of the 19 GABA~A~ channel subunit mRNAs (α1--6, β1--3, γ1--3, δ, ε, θ, π, ρ1--3) was quantified by RT-qPCR in the samples collected from the hippocampal dentate gyrus region (HP-DG), the orbitofronral cortex (OFC, Brodmann area 47), and the dorsolateral prefrontal cortex (DL-PFC, Brodmann area 9). Subunit genes that were not detected in any of the three brain regions were the π, ρ1, and ρ3 subunits.

Increased levels of mRNAs for GABA~A~ channel subunits α1, α4, α5, β1, and γ1 in the hippocampal dentate gyrus region of alcoholics
-----------------------------------------------------------------------------------------------------------------------------------

In the hippocampal dentate gyrus region of individuals without alcohol dependence, high expression of α1, α2, α4, α5, β1, β2, and γ2, modest expression of α3, β3, γ1, γ3, δ, and θ, low expression of α6, ε, and ρ2 subunit mRNAs were detected (Figure [1](#F1){ref-type="fig"}). Interestingly, the mRNA levels of α1, α4, α5, β1, and γ1 subunits were significantly higher in the HP-DG of individuals suffering from alcohol dependence than in the controls. There was a 1.5-fold (α1), 1.6-fold (α4), 1.7-fold (α5), 2.1-fold (β1), and 2.3-fold (γ1) increase of mRNA in the hippocampal dentate gyrus region of individuals suffering from alcoholism as compared to those without alcohol dependence. Stepwise linear regression identified age, PMI, and brain pH as covariates for the α5 expression level. However, inclusion of these covariates in linear regression model did not affect the significant difference in α5 expression level between the two groups. The mRNA levels of other GABA~A~ channel subunits did not differ between two groups (Figure [2](#F2){ref-type="fig"}).

![**Expression of GABA~A~ channel subunit mRNAs in the hippocampal dentate gyrus region from control subjects (*n* = 15)**. The mRNA level of each subunit was normalized to reference genes *ACTB* and *UBC* and presented as mean ± SE.](fncel-05-00030-g001){#F1}

![**Expression of GABA~A~ channel subunit mRNAs in the hippocampal dentate gyrus region of controls (•, *n* = 15) and alcoholics (◦, *n* = 13)**. Horizontal lines represented mean levels. Kruskal--Wallis ANOVA on ranks with Dunn's *post hoc* test, α1, *H*(1, 28) = 4.39, *p* = 0.036; α2, *H*(1, 28) = 1.72, *p* = 0.19; α3, *H*(1, 28) = 0.73, *p* = 0.39; α4, *H*(1, 28) = 5.41, *p* = 0.02; α 5, *H*(1, 28) = 8.83, *p* = 0.003; α6, *H*(1, 28) = 1.17, *p* = 0.28; β1, *H*(1, 28) = 9.38, *p* = 0.002; β2, *H*(1, 28) = 2.68, *p* = 0.10; γ1, *H*(1, 28) = 7.02, *p* = 0.008; γ2, *H*(1, 28) = 2.83, *p* = 0.09; γ3, *H*(1, 28) = 3.31, *p* = 0.07; δ, *H*(1, 28) = 1.07, *p* = 0.3; ρ2, *H*(1, 28) = 1.97, *p* = 0.16; θ, *H*(1, 28) = 0.38, *p* = 0.53; ε, *H*(1, 28) = 2.32, *p* = 0.13. One way ANOVA with Bonferroni *post hoc* test, β3, df = 23, *p* = 0.06.](fncel-05-00030-g002){#F2}

Decreased expression of GABA~A~ channel subunit β2 and δ mRNAs in the orbitofrontal cortex of alcoholics
--------------------------------------------------------------------------------------------------------

In the OFC of individuals without alcohol dependence, high expression of α1, α2, α4, β1, β2, and γ2, modest expression of α3, α5, β3, γ1, γ3, and δ, low expression of α6, ε, θ, and ρ2 subunit mRNAs were detected (Figure [3](#F3){ref-type="fig"}). Of particular interest is the result that the mRNA levels of the β2 and δ subunits were 26 and 47% lower, respectively, in individuals suffering from alcohol dependence as compared to those without alcohol dependence, while the mRNA expression of other subunits did not differ between the two groups (Figure [4](#F4){ref-type="fig"}). Stepwise linear regression identified age as a covariate for the β2 and δ expression level. However, inclusion of age as a covariate in linear regression model failed to affect the significant difference in the β2 and δ expression levels between the two groups.

![**Expression of GABA~A~ channel subunit mRNAs in the orbitolfrontal cortex of controls (*n* = 14)**. The mRNA level of each subunit was normalized to reference genes *PPIA* and *PGK1* and presented as mean ± SE.](fncel-05-00030-g003){#F3}

![**Expression of GABA~A~ channel subunits mRNA in the orbitofrontal cortex of controls (•, *n* = 14) and alcoholics (◦, *n* = 11)**. Horizontal lines represented mean levels. One way ANOVA with Bonferroni *post hoc* test, α3, df = 23, *p* = 0.052; α4, df = 23, *p* = 0.61; α 5, df = 23, *p* = 0.55; β2, df = 23, *p* = 0.045; ε, df = 23, *p* = 0.06. Kruskal--Wallis ANOVA on ranks with Dunn's *post hoc* test, α1, *H*(1, 25) = 2.03, *p* = 0.15; α2, *H*(1, 25) = 0.3, *p* = 0.58; α6, *H*(1, 25) = 0.51, *p* = 0.48; β1, *H*(1, 25) = 0.05, *p* = 0.83; β3, *H*(1, 25) = 1.09, *p* = 0.3; γ1, *H*(1, 25) = 0.15, *p* = 0.70; γ2, *H*(1, 25) = 1.59, *p* = 0.21; γ3, *H*(1, 25) = 0.15, *p* = 0.70; θ, *H*(1, 25) = 0.003, *p* = 0.96; ρ2, *H*(1, 25) = 0.003, *p* = 0.96; δ, *H*(1, 25) = 5.8, *p* = 0.016.](fncel-05-00030-g004){#F4}

Unaltered expression of GABA~A~ channel subunit mRNAs in the dorsolateral prefrontal cortex of alcoholics
---------------------------------------------------------------------------------------------------------

The mRNA expression profile of GABA~A~ channel subunits in the DL-PFC in individuals without alcohol dependence closely resembled that observed in the OFC (Figures [3](#F3){ref-type="fig"} and [5](#F5){ref-type="fig"}). Furthermore, no significant differences in the mRNA expression were observed for any of the subunits between alcoholics and non-alcoholic controls (Figure [6](#F6){ref-type="fig"}).

![**Expression of GABA~A~ channel subunit mRNAs in the prefrontal cortex of controls (*n* = 15)**. The mRNA level of each subunit was normalized to reference genes *ACTB* and *RPLP0* and presented as mean ± SE.](fncel-05-00030-g005){#F5}

![**Expression of GABA~A~ channel subunit mRNAs in the prefrontal cortex of controls (•, *n* = 15) and alcoholics (◦, *n* = 14)**. Horizontal lines represented mean levels. One way ANOVA with Bonferroni *post hoc* test, α1, df = 27, *p* = 0.58; α2, df = 27, *p* = 0.55; α3, df = 27, *p* = 0.45; α4, df = 27, *p* = 0.76; α5, df = 27, *p* = 0.93; α6, df = 27, *p* = 0.13; β1, df = 27, *p* = 0.19; β2, df = 27, *p* = 0.66; β3, df = 27, *p* = 0.97; γ2, df = 27, *p* = 0.36; γ3, df = 27, *p* = 0.19; δ, df = 27, *p* = 0.76; Kruskal--Wallis ANOVA on ranks with Dunn's *post hoc* test, γ1, *H*(1, 29) = 0.69, *p* = 0.41; ε, *H*(1, 29) = 0.13; θ, *H*(1, 29) = 1.29, *p* = 0.26; ρ^2^, *H*(1, 29) = 0.62, *p* = 0.43.](fncel-05-00030-g006){#F6}

Discussion
==========

The expression of specific GABA~A~ channel subunit mRNAs was altered in specific brain regions in individuals suffering from alcoholism. In particular, there was a significant increase of the α1, α4, α5, β1, and γ1 subunit mRNAs in the HP-DG; a decrease of the β2 and δ in the OFC, but no change of any subunit expression in the DL-PFC. These data complement previous expression studies in individuals suffering from alcohol dependence providing further evidence for long-term changes in the GABA~A~ channels in the CNS induced by long-term alcohol consumption (Lewohl et al., [@B33], [@B34]; Mitsyama et al., [@B41]; Thomas et al., [@B58]; Buckley and Dodd, [@B6]).

Gene expression profiling studies by, e.g., quantitative PCR using human autopsy brain tissue can be affected by many pre- and post-mortem factors such as age, gender, ethnicity, and PMI. In this study we have tried to minimize the differences between the two groups of individuals we have studied. All individuals included in the study were Caucasian males and the two groups were matched for parameters such as age, PMI, brain pH, RNA quality indicator value, and proportions of smokers and non-smokers. In addition, the sample size in each group was between 11 and 15 that falls within the group--size range providing rather reliable statistical estimation (Hynd et al., [@B24]).

GABA~A~ channels are pentameric GABA-gated chloride channels. A change of subunit composition in the GABA~A~ channel complex can directly affect its cellular and sub-cellular location as well as physiological and pharmacological properties of the channel, including ethanol sensitivity (Birnir and Korpi, [@B4]). Several studies have indicated that the expression of GABA~A~ channel subunits differs at both the mRNA and protein levels between post-mortem brains from non-alcoholic individuals and alcoholics, although the results remain somewhat ambiguous (Lewohl et al., [@B33], [@B34]; Dodd and Lewohl, [@B15]; Buckley et al., [@B7], [@B8]; Buckley and Dodd, [@B6]). It has been shown that the expression of the GABA~A~ channel subunit α1 mRNA but not protein was elevated in the superior frontal cortex of alcoholics (Lewohl et al., [@B33]; Dodd and Lewohl, [@B15]). Similarly, in our study α1 mRNA level was increased in the hippocampal dentate gyrus of alcoholic individuals. However, chronic alcohol administration to rodents decreased or did not change the α1 mRNA and protein levels in the cerebral cortex, cerebellum, or hippocampus (Uusi-Oukari and Korpi, [@B60]). This discrepancy in results between humans and rodents can potentially be attributed to the difference in, e.g., in metabolism or length of alcohol exposure, transcriptional regulation and animal models of alcohol dependence, in addition to the species difference.

GABA~A~ channels containing the α4, α5, or the δ subunit are of particular interest. These subunits are parts of extrasynaptic GABA~A~ channels that participate in generating tonic neuronal inhibition that decreases action potential frequency in neurons (Pavlov et al., [@B45]; Jin et al., [@B26]). Activation of GABA~A~ channels containing these subunits is thought to have implications for cognitive function. In a rodent model for excessive alcohol consumption, repeated ethanol withdrawals or longer ethanol exposure increased the α4 subunit protein expression in the hippocampus (Matthews et al., [@B38]; Cagetti et al., [@B9]). This is in accordance with our data where the α4 mRNA expression was elevated in alcoholic individuals as compared to the non-alcoholic subjects. In the human hippocampus, the α5 subunit is abundant in the dentate gyrus molecular layer as well as in mid-CA1 regions (Howell et al., [@B23]; Wainwright et al., [@B64]; Rissman et al., [@B49]), whereas in the rodent hippocampus, α5-containing GABA~A~ channels are only highly expressed in CA1 pyramidal neurons (Sperk et al., [@B54]). Genetic or pharmacological manipulation of α5-containing GABA~A~ channels in mice modulates hippocampus-dependent learning (Crestani et al., [@B12]; Caraiscos et al., [@B10]; Martin et al., [@B37]; Prut et al., [@B46]). It is possible that GABA~A~ α4 or α5 subunit-selective compounds may potentially be used for the treatment of alcohol-induced cognitive deficit.

Ethanol can induce the release of endogenous GABAergic neurosteroids that further enhance the GABA signaling system in neurons (Biggio et al., [@B3]). The sensitivity to neurosteroids is higher in γ1 subunit-containing GABA~A~ channels than in γ2 subunit-containing GABA~A~ channels (Puia et al., [@B47]). Chronic ethanol administration in rodents significantly increases the mRNA expression of γ1 subunit in the cerebral cortex (Devaud et al., [@B14]) and in the hippocampus (Cagetti et al., [@B9]), and similarly in our study, up-regulation of the γ1 subunit was observed in the HP-DG from alcoholic individuals. Therefore, increased sensitivity to neurosteroids of GABA~A~ channels may be associated with the alcohol dependence.

Some of the genes encoding the human GABA~A~ channel subunits are organized into clusters on chromosomes. Chromosome 4 contains four GABA~A~ channel genes: *GABRA2* (α2), *GABRA4* (α4), *GABRB1* (β1), and *GABRG1* (γ1) (Reich et al., [@B48]). As the change in the gene regulation of one GABA~A~ channel subunit may affect the transcription levels of other GABA~A~ subunit genes in the same cluster (Uusi-Oukari et al., [@B59]; Steiger and Russek, [@B55]), it is not surprising to see the up-regulation of three of them (α4, β1, and γ1), in HP-DG of alcoholic individuals in our study. It will be worth using genetic mapping approach to study whether these GABA~A~ subunit expressions are associated with specific gene polymorphisms and whether the regulation of transcription is similar for these subunit genes (Joyce, [@B28]). Since the α1, α4, α5, and β1 GABA~A~ subunits are abundant in the hippocampal dentate gyrus, the increase in the expression of these subunits may have significant functional consequence in alcohol-induced cognitive impairment. Further studies are needed to determine the protein level of these altered subunits and assess their putative functional impact in human alcoholism.

Chronic alcohol consumption in humans has been shown to cause impairment of executive and cognitive functions which require normal prefrontal cortical function (Goldstein et al., [@B19]; Crego et al., [@B11]). Here we have examined the expression of GABA~A~ channel subunits in the sub-regions of cortex, DL-PFC, and OFC from alcoholics. In the OFC of alcoholic individuals, the β2 and δ GABA~A~ subunits were significantly decreased. Whether this decrease contributes to the impaired GABAergic function in the OFC reported in studies involving alcoholics remains to be determined (Volkow et al., [@B62], [@B63]). In contrast, none of the GABA~A~ subunits were changed in the DL-OFC of individuals suffering from alcohol dependence as compared to non-alcoholic individuals. This is in agreement with two microarray studies showing no change of any GABA~A~ subunit mRNAs in the frontal cortex of alcoholic subjects (Mayfield et al., [@B39]; Flatscher-Bader et al., [@B16]).

In conclusion, we report brain area-specific selective changes in the mRNA expression of GABA~A~ channel subunits in individuals suffering from alcohol dependence compared to control cases. It is of particular interest that several of the subunits that change with chronic alcohol consumption (e.g., α4, α5, and δ) are present in many extrasynaptic GABA~A~ channels mediating tonic inhibition. As tonic inhibition has a significant role in determining baseline excitability of neurons this is perhaps not surprising but highlights the importance of GABA~A~ channels located outside of synapses for drug effects.
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###### 

**Demographic data of controls and alcoholics**.

  Subject no.      Age (years)   PMI (hours)   Brain pH   Brain regions        Smoking history   Cause of death
  ---------------- ------------- ------------- ---------- -------------------- ----------------- -------------------------------------------------------
  **CONTROLS**                                                                                   
  1                34            20.5          6.73       DL-PFC, OFC          Yes               Acute exacerbation of asthma
  2                78            6.5           6.2        DL-PFC, OFC          No                Adenocarcinoma
  3                63            72            6.9        DL-PFC, OFC, HP-DG   Yes               Coronary artery atherosclerosis
  4                82            23.5          6.4        DL-PFC, OFC          NA                Sepsis
  5                38            13.5          6.26       DL-PFC, OFC, HP-DG   Yes               Atherosclerotic cardiovascular disease
  6                69            16            6.6        DL-PFC, OFC, HP-DG   Yes               Atherosclerotic cardiovascular disease
  7                56            24            6.53       DL-PFC, OFC, HP-DG   Yes               Coronary artery atheroma
  8                59            20            6.56       DL-PFC, OFC, HP-DG   Yes               Coronary thrombosis
  9                56            25            6.1        DL-PFC               NA                Ischemic heart disease
  10               56            37            6.76       DL-PFC, OFC, HP-DG   Yes               Left ventricular scarring, hypertension, cardiomegaly
  11               82            36            6.24       DL-PFC, OFC, HP-DG   No                Myocardial infarction
  12               44            50            6.6        DL-PFC, OFC          Yes               Ischemic heart disease
  13               66            22            6.31       HP-DG                NA                Respiratory failure
  14               56            48            6.49       HP-DG                Yes               Cardiac failure
  15               43            66            6.2        HP-DG                No                Aspiration pneumonia
  16               58            12            6.46       HP-DG                Yes               Ischemic heart disease
  17               37            24            6.37       HP-DG                NA                Electrocution
  18               46            25            6.65       HP-DG                NA                Mitral valve prolapse
  19               58            15            6.71       HP-DG                No                Perforated gastric ulcer
  20               68            22            6.59       HP-DG                No                Asphyxia
  21               53            16            6.84       DL-PFC, OFC          No                Dilated cardiomyopathy
  **ALCOHOLICS**                                                                                 
  1                70            62            6.82       HP-DG                Yes               Cardiomyopathy
  2                38            22            6.78       HP-DG                Yes               Ischemic heart disease
  3                34            8.5           6.61       DL-PFC, OFC, HP-DG   Yes               Hanging
  4                77            20            6.34       DL-PFC, OFC, HP-DG   Yes               Bronchopneumonia
  5                65            32            5.66       DL-PFC               NA                Complications of chronic alcoholism
  6                50            17            6.3        HP-DG                No                Ischemic heart disease
  7                79            48            6.34       DL-PFC, OFC, HP-DG   Yes               Ischemic heart disease
  8                39            24            6.56       DL-PFC, OFC, HP-DG   Yes               Aortic stenosis
  9                56            22            6.52       DL-PFC, OFC, HP-DG   Yes               Gastro-intestinal hemorrhage
  10               59            24            6.57       DL-PFC, OFC          No                Cardiomyopathy
  11               56            15            6.66       DL-PFC, OFC, HP-DG   NA                Ischemic heart disease and emphysema
  12               56            45            6.51       DL-PFC, OFC, HP-DG   NA                Bleeding esophageal varices
  13               44            15            6.48       DL-PFC, OFC, HP-DG   No                Ischemic heart disease
  14               81            36            6.44       DL-PFC, OFC, HP-DG   Yes               Sepsis
  15               62            49            6.49       DL-PFC               Yes               Ischemic heart disease
  16               66            11.5          6.4        DL-PFC               Yes               Pneumonia
  17               53            57            6.75       DL-PFC, OFC, HP-DG   Yes               Chronic airflow limitation
  18               61            24            6.52       DL-PFC, OFC          Yes               Ischemic heart disease
  19               57            18            6.6        DL-PFC, OFC          Yes               Ischemic heart disease

*PMI, post-mortem interval; DL-PFC, dorsolateral prefrontal cortex; OFC, orbitofrontal cortex; HP-DG, hippocampal dendate gyrus; NA, not available*.

###### 

**Human primers list for quantitative real-time RT-PCR**.

  Gene               Primer                                 Product size (bp)   Reference number
  ------------------ -------------------------------------- ------------------- ------------------
  α1 (*GABRA1*)      F: GGATTGGGAGAGCGTGTAACC               66                  NM_000806
                     R: TGAAACGGGTCCGAAACTG                                     
  α2 (*GABRA2*)      F: GTTCAAGCTGAATGCCCAAT                160                 NM_000807
                     R: ACCTAGAGCCATCAGGAGCA                                    
  α3 (*GABRA3*)      F: CAACTTGTTTCAGTTCATTCATCCTT          102                 NM_000808
                     R: CTTGTTTGTGTGATTATCATCTTCTTAGG                           
  α4 (*GABRA4*)      F: TTGGGGGTCCTGTTACAGAAG               105                 NM_000809
                     R: TCTGCCTGAAGAACACATCCA                                   
  α5 (*GABRA5*)      F: ACGGTGGGCACTGAGAACAT                64                  NM_000810
                     R: GGAAGTGAGCTGTCATGATTGTG                                 
  α6 (*GABRA6*)      F: ACCCACAGTGACAATATCAAAAGC            67                  NM_000811
                     R: GGAGTCAGGATGCAAAACAATCT                                 
  β1(GABRB1)         F: GTACAAAATCGAGAGAGTCTGGG             144                 NM_000812
                     R: GCG AATGTCATATCCTTTGAGCA                                
  β2(*GABRB2*)       F: GCAGAGTGTCAATGACCCTAGT              137                 NM_021911
                     R: TGGCAATGTCAATGTTCATCCC                                  
  β3(*GABRB3*)       F: CAAGCTGTTGAAAGGCTACGA               108                 NM_000814
                     R: ACTTCGGAAACCATGTCGATG                                   
  γ1(*GABRG1*)       F: CCTTTTCTTCTGCGGAGTCAA               91                  NM_173536
                     R: CATCTGCCTTATCAACACAGTTTCC                               
  γ2(*GABRG2*)       F: CACAGAAAATGACGGTGTGG                136                 NM_000816
                     R: TCACCCTCAGGAACTTTTGG                                    
  γ3(*GABRG3*)       F: AACCAACCACCACGAAGAAGA               113                 NM_033223
                     R: CCTCATGTCCAGGAGGGAAT                                    
  δ (*GABRD*)        F: ACCACGGAGCTGATGAACTT                109                 NM_000815
                     R: AGGGCATGTAGGATTGGATG                                    
  ε (*GABRE*)        F: TGGATTCTCACTCTTGCCCTCTA             107                 NM_004961
                     R: GGAGTTCTTCTCATTGATTTCAAGCT                              
  θ (*GABRQ*)        F: CCAGGGTGACAATTGGCTTAA               63                  NM_018558
                     R: CCCGCAGATGTGAGTCGAT                                     
  π (*GABRP*)        F: GGCCTTGCTAGAATATGCAGTTG             76                  NM_014211
                     R: CTTTGTTGTCCCCCTATCTTTGG                                 
  ρ1(*GABRR1*)       Hs00266687_m1 from applied biosystem   94                  NM_002042
  ρ2 (*GABRR2*)      F: CCTAGAAGAGGGCATAGACATCG             99                  NM_002043
                     R: TCCAGTAGCTGCTGCATTGTTTG                                 
  ρ3 (*GABRR3*)      F: TGATGCTTTCATGGGTTTCA                111                 NM_001105580
                     R: CGCTCACAGCAGTGATGATT                                    
  β-actin (*ACTB*)   F: CCTGGCACCCAGCACAAT                  144                 NM_001101
                     R: GGGCCGGACTCGTCATACT                                     
  *RPLP0*            F: CCTCATATCCGGGGGAATGTG               95                  NM_001002
                     R: GCAGCAGCTGGCACCTTATTG                                   
  *PPIA*             F: CCCACCGTGTTCTTCGACAT                116                 NM_021130
                     R: CCAGTGCTCAGAGCACGAAA                                    
  *PKG1*             F: AGGGAAAAGATGCTTCTGGG                71                  NM_000291
                     R: AAGTGAAGCTCGGAAAGCTTCTAT                                
  *UBC*              F: CGGTGAACGCCGATGATTAT                124                 NM_021009
                     R: ATCTGCATTGTCAAGTGACGA                                   

###### 

**Analysis of normality of RT-qPCR data distribution by Shapiro--Wilk normality test (*p* values are shown below)**.

       HP-DG         OFC           DL-PFC
  ---- ------------- ------------- -------------
  α1   *p* \< 0.05   *p* \< 0.05   *p* = 0.239
  α2   *p* \< 0.05   *p* \< 0.05   *p* = 0.878
  α3   *p* \< 0.05   *p* = 0.977   *p* = 0.741
  α4   *p* \< 0.05   *p* = 0.994   *p* = 0.522
  α5   *p* \< 0.05   *p* = 0.114   *p* = 0.256
  α6   *p* \< 0.05   *p* \< 0.05   *p* = 0.493
  β1   *p* \< 0.05   *p* \< 0.05   *p* = 0.214
  β2   *p* \< 0.05   *p* = 0.75    *p* = 0.111
  β3   *p* = 0.429   *p* \< 0.05   *p* = 0.073
  γ1   *p* \< 0.05   *p* \< 0.05   *p* \< 0.05
  γ2   *p* \< 0.05   *p* \< 0.05   *p* = 0.821
  γ3   *p* \< 0.05   *p* \< 0.05   *p* = 0.349
  δ    *p* \< 0.05   *p* \< 0.05   *p* = 0.281
  ε    *p* \< 0.05   *p* = 0.135   *p* \< 0.05
  θ    *p* \< 0.05   *p* \< 0.05   *p* \< 0.05
  ρ2   *p* \< 0.05   *p* \< 0.05   *p* \< 0.05

**p* \< 0.05 indicates the data are not normally distributed. HP-DG, hippocampal dendate gyrus; OFC, orbitofrontal cortex; DL-PFC, dorsolateral prefrontal cortex*.
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